Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Current Issues in Pharmacy and Medical Sciences
Volume 28 (2015): Issue 2 (June 2015)
Open Access
Evidence of use: A selective COX-2 inhibitor in the treatment of experimental chronic pancreatitis induced by Dibutyltin dichloride
Sergij Sukhodolya
Sergij Sukhodolya
,
Tetyana Falalyeyeva
Tetyana Falalyeyeva
,
Olena Kuryk
Olena Kuryk
,
Victoriya Petrushenko
Victoriya Petrushenko
and
Tetyana Beregova
Tetyana Beregova
| Jul 16, 2015
Current Issues in Pharmacy and Medical Sciences
Volume 28 (2015): Issue 2 (June 2015)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Jul 16, 2015
Page range:
131 - 135
Received:
Jan 23, 2015
Accepted:
Mar 24, 2015
DOI:
https://doi.org/10.1515/cipms-2015-0059
Keywords
chronic pancreatitis
,
selective COX-2 inhibitor
,
Dibutyltin dichloride
© 2015
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.